Article Information
History
- May 24, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Anna L. Talbot1,
- Pia Egerup1,
- Anne L. Lunøe2,
- Karen K. Jensen1,
- Marie L.T. Chonovitsch1,
- Anne-Sofie Korsholm2,
- Ida Behrendt-Møller1,
- Tanja S. Hartwig1,
- David Westergaard1,
- Kilian Vomstein1,
- Elisabeth C. Larsen2,
- Barbara M. Fischer3,4 and
- Henriette S. Nielsen1,4,*
- 1The Recurrent Pregnancy Loss Unit, The Capital Region, Copenhagen university hospital Hvidovre, 2650 Hvidovre, Denmark
- 2The Recurrent Pregnancy Loss Unit, The Capital Region, Copenhagen university hospital Rigshospitalet, Copenhagen, Denmark
- 3Department of Clinical Physiology & Nuclear Medicine, Copenhagen University Hospital Rigshospitalet, 2100 Copenhagen, Denmark
- 4Department of Clinical Medicine, Faculty of Health and Medical Science, University of Copenhagen, 2100 Copenhagen, Denmark
- ↵*Correspondence address. The Recurrent Pregnancy Loss Unit, The Capital Region, Copenhagen University Hospital Hvidovre, Kettegaard Alle 30, DK-2650 Hvidovre, Denmark. E-mail: henriette.svarre.nielsen{at}regionh.dk
Posted May 24, 2024.
Hydroxychloroquine treatment for recurrent pregnancy loss: a study protocol for a randomized, double-blind, placebo-controlled trial
